Yuantas-CW25 Bora Pharmaceuticals Co. Ltd. logo

Yuantas-CW25 Bora Pharmaceuticals Co. Ltd. (059772)

Market Closed
5 Aug, 05:30
TWSE TWSE
NT$
2. 89
+0.63
+27.8761%
NT$
- Market Cap
- P/E Ratio
- Div Yield
33,000 Volume
- Eps
NT$ 2.26
Previous Close
Add Transaction
Day Range
2.89 3.02
Year Range
1.01 6.6
Want to track 059772 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

059772 closed Wednesday higher at NT$2.89, an increase of 27.8761% from Tuesday's close, completing a monthly increase of 22.4576% or NT$0.53. Over the past 12 months, 059772 stock gained 86.4516%.
059772 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

059772 Chart

Yuantas-CW25 Bora Pharmaceuticals Co. Ltd. (059772) FAQ

What is the stock price today?

The current price is NT$2.89.

On which exchange is it traded?

Yuantas-CW25 Bora Pharmaceuticals Co. Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 059772.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Yuantas-CW25 Bora Pharmaceuticals Co. Ltd. ever had a stock split?

No, there has never been a stock split.

Yuantas-CW25 Bora Pharmaceuticals Co. Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
- CEO
TWSE Exchange
- ISIN
Taiwan Country
- Employees
- Last Dividend
- Last Split
- IPO Date
Yuantas-CW25 Bora Pharmaceuticals Co. Ltd. is a warrant associated with Bora Pharmaceuticals, a leading entity in the contract development and manufacturing organization (CDMO) sector. This warrant provides investors with the opportunity to buy the underlying shares of Bora Pharmaceuticals at a predetermined price before the warrant's expiration date. Bora Pharmaceuticals specializes in offering a broad spectrum of services, from drug development and clinical trial manufacturing to commercial-scale production. It caters to a variety of pharmaceutical companies, assisting them in bringing pharmaceutical products to market efficiently and cost-effectively. The warrant allows investors to potentially capitalize on the growth of the pharmaceutical sector, which is driven by increasing demand for pharmaceutical innovations and medications globally. In the financial market, such warrants are significant as they provide flexibility and leverage for investors wishing to gain exposure to the healthcare and pharmaceutical industries without immediate capital expenditure that comes with outright share purchases.

Contact Information

Address: -
Phone: -